Anaplastic lymphoma kinase (ALK) inhibitors in the treatment of ALK-driven lung cancers

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Anaplastic lymphoma kinase (ALK) inhibitors in the treatment of ALK-driven lung cancers
Authors
Keywords
Acquired drug resistance, Catalytic spine, Fusion protein, K/E/D/D, Protein kinase inhibitor classification, Targeted cancer therapy
Journal
PHARMACOLOGICAL RESEARCH
Volume 117, Issue -, Pages 343-356
Publisher
Elsevier BV
Online
2017-01-08
DOI
10.1016/j.phrs.2017.01.007

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.